WBB Initiates Cidara Therapeutics With Sell

By: via Benzinga
Analysts at WBB initiated coverage on Cidara Therapeutics Inc (NASDAQ: CDTX) with a Sell rating. The target price for Cidara ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.